Company
United StatesPublic company, NASDAQ: MLYSMineralys Therapeutics, Inc. (NASDAQ: MLYS), Radnor, PA – FDA Inspections
Inspection records and compliance data for Mineralys Therapeutics, Inc. in Radnor, PA. 1 FDA inspection on record, last inspected September 22, 2026. Publicly traded as NASDAQ: MLYS.
Company Profile
This profile covers Mineralys Therapeutics, Inc. based in Radnor, PA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected September 22, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 22, 2026 | Not classified | Human Drugs | 1344656 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Mineralys Therapeutics, Inc.
Stock ticker
MLYS
Exchange
NASDAQ
Share price
$15.50
Market cap
$1.4B
Price as of
November 13, 2026
FEI Number
3020361651
Address
150 N Radnor Chester Rd Ste F200, Radnor, PA 19087-5245, United States
Country
United States
ID: ba6e9993-1dca-45da-a6a1-73037c295db9